abstract |
The invention provides hepatitis B virus (HBV) infection, hepatitis C virus (HCV) infection, type D in a patient using an effective amount of a compound selected from the group consisting of formulas (I)-(IV) A composition and method of treatment for treating hepatitis virus (HDV) infection or proliferative disease:n n n n n n n n Wherein the substituents are as described in the specification. Also described are pharmaceutical compositions comprising such compounds in combination with other HBV, HCV or HDV agents. |